Early research (Phase 1)Study completedNCT00727766What this trial is testingOral Clofarabine for Acute Myeloid LeukemiaWho this might be right forLeukemia, Myeloid, Acute Washington University School of Medicine 25
Not applicableNo Longer AvailableNCT02624570What this trial is testingMidostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation ChemotherapyWho this might be right forAcute Myeloid Leukemia (AML) WithFLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT00004056What this trial is testingCombination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 35
Not applicableUnknownNCT00336206What this trial is testingLow Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic LeukemiaWho this might be right forB-Cell Chronic Lymphocytic Leukemia Tawam Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02310321What this trial is testingASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.Who this might be right forAcute Myeloid LeukemiaFLT3-mutated Acute Myeloid Leukemia Astellas Pharma Inc 97
Post-approval studies (Phase 4)Study completedNCT00460733What this trial is testingSOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.Who this might be right forColles' Fracture Sanofi 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT04329325What this trial is testingBlinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaPhiladelphia Chromosome-Positive Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Looking for participantsNCT04585490What this trial is testingPersonalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLCWho this might be right forNon Small Cell Lung CancerNSCLC, Stage IIINsclc Maximilian Diehn 48
Early research (Phase 1)Study completedNCT02236013What this trial is testingASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Astellas Pharma Global Development, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT00198432What this trial is testingChemoradiotherapy of NSCLC Stage IIIBWho this might be right forNSCLC Stage IIIBConcomitant Radiochemotherapy Intergroupe Francophone de Cancerologie Thoracique 130
Testing effectiveness (Phase 2)UnknownNCT04286958What this trial is testingCamrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCCWho this might be right forEsophageal Cancer Hebei Medical University Fourth Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00417248What this trial is testingCisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Nasser Hanna, M.D. 8
Testing effectiveness (Phase 2)Study completedNCT01183416What this trial is testingHigh-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell TransplantationWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00662948What this trial is testingZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)Who this might be right forLymphoma PETHEMA Foundation 149
Large-scale testing (Phase 3)Study completedNCT00533949What this trial is testingHigh-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryWho this might be right forLung CancerRadiation Toxicity Radiation Therapy Oncology Group 544
Testing effectiveness (Phase 2)Study completedNCT00492206What this trial is testingStudy of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLCWho this might be right forNon Small Cell Lung Cancer (NSCLC) University of Pittsburgh 40
Testing effectiveness (Phase 2)Ended earlyNCT04914676What this trial is testingAccelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete RemissionWho this might be right forAcute Myeloid Leukemia University of Florida 5
Not applicableLooking for participantsNCT05000697What this trial is testingChemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and WaitWho this might be right forRectal CancerConsolidation Hospital Alemão Oswaldo Cruz 216
Large-scale testing (Phase 3)UnknownNCT03308552What this trial is testingRadiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02Who this might be right forEsophageal Neoplasms Chinese Academy of Medical Sciences 164
Large-scale testing (Phase 3)Ended earlyNCT01246752What this trial is testingHaematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CRWho this might be right forLeukemia, Myeloid, Acute University Hospital Carl Gustav Carus 143